Customized Problem-Solving Diagnosis for Manufacturing SMEs with Sales Over 5 Billion Won

The Small and Medium Business Corporation announced on the 10th that it is recruiting participants for the '2024 2nd Challenge Diagnosis for Participating Companies' to revitalize small and medium-sized enterprises (SMEs) and overcome the economic downturn. The Challenge Diagnosis is a problem-solving diagnostic program where experts in various fields identify issues faced by SMEs, analyze the causes, and provide solutions tailored to the characteristics of each company.


Small and Medium Business Corporation

Small and Medium Business Corporation

View original image

The eligible applicants are SMEs engaged in manufacturing with sales of 5 billion KRW or more, and the final selection will be made through a review committee among the applicants. The Corporation selected a total of 52 companies through the first recruitment in April and is currently supporting them, and plans to select about 50 companies in this second recruitment.


Selected companies can choose one of three fields: ▲Production Management ▲Quality Control ▲Financial Management, and receive intensive diagnostic services from experts in the chosen field. Field experts will conduct intensive diagnostics through on-site visits to the selected companies a total of 10 times from July to October. After the diagnosis is completed, the Corporation plans to provide information on linked support projects to companies with outstanding performance.



Kang Seok-jin, President of the Small and Medium Business Corporation, said, “The answer to restoring corporate dynamism and improving organizational health must be found on-site,” adding, “Through the Challenge Diagnosis, the Corporation’s representative on-site problem-solving diagnostic program, we will enhance the competitiveness of SMEs and contribute to creating a vibrant industrial environment.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing